Form 4: Core Laboratories Inc. Insider Trading Activity
Statement of Changes in Beneficial Ownership
Mark Tattoli, SVP, Gen Counsel & Secretary of Core Laboratories Inc., reported transactions involving company stock on May 1, 2026.
Summary
- Mark Tattoli, Senior Vice President, General Counsel & Secretary of Core Laboratories Inc., engaged in stock transactions on May 1, 2026.
- He disposed of 97 shares of common stock at a price of $14.07 per share.
- He acquired 250 shares of common stock through a transaction coded 'M' (likely a grant or award) with no reported price.
- Following these transactions, Tattoli beneficially owns 27,513.62 shares directly and an additional 1,694.84 shares indirectly through a 401(k) plan.
- Restricted shares are also held, with 250 shares acquired on May 1, 2026, as part of a vesting schedule over six years.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, reflecting routine insider stock transactions without significant positive or negative implications for the company's valuation.
Positives
- Acquisition of 250 shares of common stock, indicating continued equity participation.
- Vesting of restricted shares, suggesting ongoing commitment and service to the company.
Negatives
- Disposal of 97 shares of common stock, which could be interpreted as a reduction in direct holdings.
Future Outlook
The filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and provide transparency into executive stock dealings. This filing indicates routine activity rather than a significant strategic shift.
Stakeholder Impact
- Shareholders: Increased transparency into executive stock ownership and transactions.
- Employees: Potential indication of executive confidence or compensation structure.
- Management: Compliance with SEC regulations regarding insider trading.
Key Dates
| Date | Description |
|---|---|
| 05/01/2026 | Date of earliest transaction and transaction date for stock disposal and acquisition. |
| 05/04/2026 | Date of report signature. |
Keywords
Form 4, Insider Trading, Core Laboratories Inc., CLB, Stock Transaction, Beneficial Ownership, Restricted Stock, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.